Statins tied to lower risk of death from ovarian cancer
Lipophilic statins seem to have the strongest association, researchers say
In a large observational study of women with epithelial ovarian cancer, use of a statin was associated with a significant reduction in ovarian-cancer-specific mortality.
The benefit was greatest in those taking a lipophilic statin, such as simvastatin or lovastatin, according to results presented during the American Association for Cancer Research second virtual annual meeting.
